2023/01/18

1. The operational plan and budget proposal for the fiscal year 2023 of the company.

2. Review of the applicable manager scope case for the company's salary and compensation pre-approval by the Compensation Committee.

3. Current salary and remuneration items for the company’s directors and managers.

4. The 2022 year-end bonus distribution plan for the chairman of the company.

5. Performance bonus distribution case for the company’s managers in 2022.

2023/03/17

1. Remuneration distribution case for employees and directors in 2022.

2. 2022 business report and financial statements.

3. Surplus distribution case for 2022.

4. Capital reserve cash distribution case.

5. Evaluation and appointment case for the independence and suitability of the company's signing accountant.

6. Issue the company’s 2022 “Internal Control System Statement”.

7. Application for extension of short-term credit limit from the bank case.

8. Proposed revision of the company’s “Code of Corporate Governance Practice”.

9. Proposed revision of the company’s “Code of Practice for Sustainable Development”.

10. Comprehensive re-election of directors (including independent directors).

11. The company accepts matters related to shareholders’ nomination of director candidates.

12. Lifting the director’s non-competition case.

13. The company accepts matters related to shareholder proposals.

14. A list of candidates for directors (including independent directors) proposed to be nominated by the board of directors.

15. Agenda for the company’s 2023 regular shareholders’ meeting.

2023/05/15

1. Financial report for the first quarter of 2023.

2. Proposed establishment of the company's "Audit Methods for Pre-Approval of Certified Accountants Providing Uncertain Services" case.

2023/06/09

1. Chairman selection case.

2. Appointment of members of the third salary and remuneration committee of the company.

2023/07/31

1. Financial report for the second quarter of 2023.

2. Determination of the cash dividend and cash distribution base date for capital reserves of the company.

3. Renewal of the company’s directors and key employees’ liability insurance.

4. The company’s individual remuneration distribution plan for directors in 2022.

5. Distribution of manager remuneration for the year of 2022.

6. Salary adjustment case for the company's managers.

7. Director Chen Junwei’s emolument case.

8. Proposed planning and preparation for the company's investment in Tseng Hsiang Life Science LTD. (Proposed by Director Chen Junwei)

2023/11/07

1. Financial report for the third quarter of 2023.

2. The company’s annual internal audit plan for 2024.

3. Proposed revision of the company’s “Internal Audit Implementation Rules”.

4. Proposed revision of the company’s “Approval Authority Table”.

5. Proposed revision of the company's "Transaction Management Operations for Group Enterprises, Related Companies, Specific Companies and Related Persons".

6. Proposed revision of the company’s “Rules of Procedure for Shareholders’ Meetings”.

7. Propose to lift the non-competition restrictions imposed by the company’s managers.